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ABSTRACTS
Gregory L. Moneta, MD, Abstracts Section EditorPaint-Only is Equivalent to Scrub-and-Paint in Preoperative Prepara-
tion of Abdominal Surgery Site
Ellenhorn JDI, Smith DD, Schwarz RE, et al. J Am Coll Surg 2005;
201:737-41.
Conclusion: A paint with povidone-iodine by itself provides equal
preoperative preparation of the abdominal wall as a scrub with povidone-
iodine soap, followed by paint with povidone-iodine.
Summary: The authors conducted a prospective randomized trial
comparing scrub-and-paint with povidone-iodine soap followed by absorp-
tion with a sterile towel and subsequent paint with povidone-iodine versus
surgical site preparation with paint only of povidone-iodine. The primary
end point was wound infection at 30 days with wound infection defined as
clinical signs of infection requiring therapeutic intervention. Excluded pa-
tients included those with active infection at the time of operation, known
sensitivity to iodine, neutropenia, or insertion of prosthetic material during
operation. Patients were randomized to a scrub-and-paint group or a paint
only group with povidone-iodine.
There were 115 patients randomized to the scrub-and-paint arm and
119 to the paint only arm of the trial. Patients were well matched with
respect to surgical co-morbidities, age, operative time, drains, surgical
procedure, and prophylactic antibiotic use. There were 12 wound infections
in the scrub-and-paint patients (10%) and 12 wound infections in the paint
only patients (10%).
Comment: These data apply only to clean and clean-contaminated
cases that do not involve placement of a prosthetic device. While the data are
interesting, they do not provide guidance as to the proper surgical prep site
technique for patients undergoing insertion of prosthetic grafts. The optimal
surgical prep site technique with respect to insertion of prosthetic vascular
grafts remains to be determined.
Autologous Transplantation of Granulocyte Colony–Stimulating
Factor–Mobilized Peripheral Blood Mononuclear Cells Improves
Critical Limb Ischemia in Diabetes
Huang P, Li S, Han M, et al. Diabetes Care 2005;28:2155-60.
Conclusion: Autologous transplantation of granulocyte colony stim-
ulating factor mobilized peripheral blood mononuclear cells and improves
critical limb ischemia in patients with diabetes.
Summary: Granulocyte colony-stimulating factor when injected can
result in mobilization of stem-progenitor cells and their peripheral blood
mononuclear cells (PBMNC) these cells can then be collected and trans-
planted through the use of multiple intramuscular injections into ischemic
limbs. In this study 28 patients with diabetes and critical limb ischemia were
enrolled in a randomized study to evaluate the effect of G-CSF mobilized
peripheral blood mononuclear cells for treatment of critical limb ischemia.
Patients were randomized to either a transplant or control group. The
transplant group received subcutaneous injections of recombinant human
G-CSF for 5 days. Stem-progenitor cells and their PBMNCs were collected
and then transplanted into ischemic limbs through the use of multiple
intramuscular injections. Follow up extended for at least 3 months.
At the end of 3 months of follow up laser Doppler blood perfusion of
lower limbs increased from 0.44  0.11 to 0.57  0.14 perfusion units in
the patients with the transplanted stem-progenitor cells versus controls
(P  0.001). In the patients with the transplanted cells the mean ankle
brachial index also increased from 0.50 0.21 to 0.63 0.25 (P 0.001).
In the transplanted patients, 14 of 18 limb ulcers (77.8%) completely healed.
Limb ulcers healed in 7 of 18 limbs in the control group (38.9%), p 0.016.
There were no lower limb amputations in the transplanted patients and 5
amputations in the control group (P  0.007). There were also significant
improvements in the angiographic scores of the transplant group compared
to the control group (P  0.003).
Comment: This is a new approach to therapeutic angiogenesis using
transplanted stem cells to induce lower extremity angiogenesis. The results
of this study are encouraging and should foster design of larger studies to
more fully assess the therapeutic potential of using stem cells as angiogenic
mediators.
Is Duplex Surveillance of Value After Leg Vein Bypass Grafting? The
Principle Results of the Vein Graft Surveillance Randomized Trial
(VGST)
Davies AH, Howdon AG, Thompson SG, and the VGST Participants.
Circulation 2005;112:1985-91.
426Conclusion: Intensive postoperative graft surveillance with duplex
scanning following lower extremity vein bypass graft operations does not
result in lower amputation rates than a simple program of clinical surveil-
lance.
Summary: This was a multicenter, randomized, prospective, con-
trolled clinical trial. There were 594 patients with a patent vein graft 30 days
following surgery. These patients were randomized to either clinical follow
up alone or a duplex follow up program with studies at 6 weeks and then 3,
6, 9, 12, and 18 months postoperatively. Approximately 2/3 of the grafts
were placed for critical ischemia with 2/3 of the distal anastomoses to the
popliteal artery either above or below the knee. Approximately 1/3 of the
patients in each group had diabetes and the median age was 70 years in each
group. Ipsilateral greater saphenous vein was used in 92% of the clinical
follow up group and 94% of the duplex follow up group.
There are no differences in the clinical and duplex surveillance groups
with respect to amputation rates (7% for each group) in vascular mortality
(3% v 4%) at 18 months. There were more stenoses at 18 months in the
clinical group (19% v 12%, P  0.04). Primary patency, primary assisted
patency, and secondary patency were similar in the clinical group (69%,
75%, and 80% and the duplex group 67%, 76%, and 79%). There were no
apparent differences in health related quality of life but the duplex surveil-
lance program was more costly by an average of 495 pounds more per
patient.
Comment: Vein graft stenoses develop more frequently in longer
grafts (ie tibial distal targets), grafts placed for limb salvage, disadvantaged
grafts (composite grafts, arm vein grafts) and perhaps in patients undergoing
repeat procedures. In this paper most of the patients probably had primary
operations as evidenced by the high level of use of ipsilateral greater
saphenous vein, 2/3 of the anastomoses were to the popliteal artery, and
amputation rates appeared to have been analyzed using both claudicants and
limb salvage patients for the life table, a bit of a no-no. In short, if ever there
were a group of patients who are unlikely to benefit from duplex surveillance,
this is the group. This paper should not lead one to abandon vascular
laboratory duplex surveillance for vein grafts potentially at increased risk for
stenosis as noted above. However, the data does suggest that when a vein
graft is placed to a popliteal artery using ipsilateral saphenous vein, duplex
surveillance may not be of much benefit in reducing amputations over the
short run.
Percutaneous Management of Chronic Mesenteric Ischemia: Outcomes
After Intervention
Landis MS, Rajan DK, Simons ME, et al. J Vasc Intervention Radiol
2005;16:1319-25.
Conclusion: Percutaneous transluminal angioplasty of the celiac
and superior mesenteric arteries is technically feasible, provides good
initial results, but often requires subsequent interventions to maintain
patency.
Summary: This was a retrospective review of patients treated with
percutaneous angioplasty for chronic mesenteric ischemia from the period of
January 1986 to August 2003. There were 29 patients treated with a mean
age of 62 years. Symptoms were felt to be consistent with chronic mesenteric
ischemia. All patients underwent angiography and angioplasty with or
without stent placement based on angiographic and/or pressure gradient
findings. Kaplan-Meier life table methods were used to determine primary
and assisted primary patency rates.
There were a total of 63 interventions performed in the 29 patients.
Forty-six interventions were percutaneous angioplasty alone and 17 involved
placement of stents. There were 34 interventions for SMA stenosis or
occlusion and 17 interventions for celiac artery stenosis or occlusion with 4
interventions performed on aortomesenteric graft stenoses.
Technical success was 97%. Defining clinical success as resolution of
symptoms, clinical success was 90%. Mean follow up was 28.3 months.
Primary patency for all interventions at 3, 6, and 12 months was 82.7% (95%
CI: 68.7-96.7), 78.9% (66.7-91.1) and 70.1% (55.1-85.6) respectively. At
3, 6, and 12 months primary assisted patency for all interventions was 87.9%
(79.0-5.3), 87.9% (79.2-95.1) and 87.9% (77.3-98.3), respectively. There
were an average of 1.9 interventions performed per patient. There was one
major complication (3.4%) and 3 minor complications (10.3).
Comment: There is accumulating data regarding the expected results
of percutaneous interventions for mesenteric artery stenosis. Excellent tech-
nical success can be anticipated but the need for repeat intervention to
maintain long term patency should be expected.
